Open Access

Implementing an SGLT2i for HFrEF treatment in my practice.

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Sponsored by Boehringer Ingelheim & Eli Lilly

Congress Presentation

About the speaker

Professor Andrew Stewart Coats

Heart Research Institute, Sydney (Australia)
112 presentations
22 followers

2 more presentations in this session

Introduction, recap and overview of evidence for SGLT2 inhibitors in HFrEF.

Speaker: Professor J. Butler (Dallas, US)

Thumbnail

Panel discussion.

Speaker: Professor S. Anker (Berlin, DE)

Thumbnail

Access the full session

SGLT2 inhibitors in practice (part 3): the case for early intervention in HFrEF

Speakers: Professor A. Stewart Coats, Professor J. Butler, Professor S. Anker
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb